Page last updated: 2024-09-03

y 590 and indolidan

y 590 has been researched along with indolidan in 1 studies

Compound Research Comparison

Studies
(y 590)
Trials
(y 590)
Recent Studies (post-2010)
(y 590)
Studies
(indolidan)
Trials
(indolidan)
Recent Studies (post-2010) (indolidan)
5002510

Protein Interaction Comparison

ProteinTaxonomyy 590 (IC50)indolidan (IC50)
cAMP-specific 3',5'-cyclic phosphodiesterase 4AHomo sapiens (human)0.15
cAMP-specific 3',5'-cyclic phosphodiesterase 4BHomo sapiens (human)0.15
cAMP-specific 3',5'-cyclic phosphodiesterase 4CHomo sapiens (human)0.15
cAMP-specific 3',5'-cyclic phosphodiesterase 4DHomo sapiens (human)0.15
cGMP-inhibited 3',5'-cyclic phosphodiesterase BHomo sapiens (human)3.54
cGMP-inhibited 3',5'-cyclic phosphodiesterase AHomo sapiens (human)3.54

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Beedle, EE; Hayes, JS; Kauffman, RF; Krushinski, JH; Pollock, GD; Robertson, DW; Wilson, H; Wyss, V1

Other Studies

1 other study(ies) available for y 590 and indolidan

ArticleYear
Dihydropyridazinone cardiotonics: the discovery and inotropic activity of 1,3-dihydro-3,3-dimethyl-5-(1,4,5,6-tetrahydro-6-oxo-3-pyridazinyl)-2H -indol-2- one.
    Journal of medicinal chemistry, 1986, Volume: 29, Issue:10

    Topics: Administration, Oral; Animals; Cardiotonic Agents; Cats; Dogs; Female; In Vitro Techniques; Indoles; Male; Myocardial Contraction; Oxindoles; Platelet Aggregation; Pyridazines; Structure-Activity Relationship

1986